Hematological Cancer
8
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
The Effect of Art-Based Intervention on Fatigue, Anxiety, Perception of Nurse Presence, and Quality of Life in Patients With Hematological Cancers
Parental Support Intervention in an Advanced Oncological Context
Progressive Relaxation and Psychoeducation in Patients With Hematological Malignancies
Enhanced Monitoring for Better Recovery and Cancer Experience in Greater Manchester
Evaluation of the Impact of Sports-inspired Onco-coaching on Health-related Quality's Life of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells
MethylphenIdate for Fatigue in Haematological Cancer
Patient-Reported Outcomes Integrated in the Follow-up of Patients With Hematological Cancer
Retrospective Survey of Re-treatment With Bortezomib